Table 2 Fractions of cells in specific phases of the cell cycle after culture of cancer cell lines in presence or absence of LACE.
| Â | DEAD | G2 | S | G1 |
|---|---|---|---|---|
AGS control | 5.77% | 17.67% | 28.66% | 34.68% |
AGS LACE | 12.24% | 16.69% | 0% | 52.93% |
A549 control | 9.35% | 13.43% | 32.13% | 29.55% |
A549 LACE | 8.94% | 12.03% | 3.40% | 44.46% |
Jurkat control | 22.45% | 6.60% | 30.59% | 26.70% |
Jurkat LACE | 11.61% | 1.42% | 0% | 71.45% |
HELA control | 6.59% | 14.24% | 19.05% | 48.58% |
HELA LACE | 14.77% | 9.34% | 15.31% | 52.19% |
B16 control | 18.42% | 6.13% | 27.57% | 33.84% |
B16 LACE | 10.98% | 6.21% | 4.57% | 57.46% |